Name | 5-chloro-7-(trifluoromethyl)-1,4-dihydroquinoxaline-2,3-dione |
---|---|
Synonyms |
5-chloro-7-trifluoromethyl-1,4-dihydroquinoxaline-2,3-dione
2,3-Quinoxalinedione,5-chloro-1,4-dihydro-7-(trifluoromethyl) 5-Chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione 5-Chloro-1,4-dihydro-7-(trifluoromethyl)-2,3-quinoxalinedione Acea 1011 C9H4ClF3N2O2 |
Density | 1.586g/cm3 |
---|---|
Molecular Formula | C9H4ClF3N2O2 |
Molecular Weight | 264.58800 |
Exact Mass | 263.99100 |
PSA | 65.72000 |
LogP | 1.88860 |
Index of Refraction | 1.519 |
~94% 153504-72-4 |
Literature: The State of Oregon, acting by and through The Oregon State Board of Higher Education, acting for and on behalf of The Oregon Health Sciences University; The University of Oregon; The Regents of the University of California Patent: US5514680 A1, 1996 ; US 5514680 A |
~% 153504-72-4 |
Literature: Zheng, Hua; Espitia, Stephen A.; Ilyin, Victor; Hawkinson, Jon E.; Woodward, Richard M.; Weber, Eckard; Keana, John F. W. Bioorganic and Medicinal Chemistry Letters, 1996 , vol. 6, # 4 p. 439 - 440 |